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ABSTRACT
Background: Multiple chronic condition is common in older adults with diabetes.
Several prior studies have shown that having multiple chronic condition impact
cardiometabolic risk factor controls (i.e., blood pressure, High-density lipoprotein (HDL)
cholesterol level, and high glycated hemoglobin (HbA1c). However, it is not clear
whether these results extend to a multiethnic sample of older adults.
Objectives:
1). Examine the association between Comorbidity profile and ABCs goals achievement.
2). Examine whether the association between comorbidity profile and ABCs goals
achievement is moderated by race/ethnicity.
Methods: A sample of 3532 participants from Health and Retirement Study (HRS) years
2010 and 2012 and corresponding HRS Biomarker data were included in this analysis.
Individual without complete diabetes status and those with missing value of all outcome
variables were excluded. The main outcome measures were three cardiometabolic risk
factor controls (blood pressure control, glycated hemoglobin (HbA1c) control and HDL
cholesterol control), which measured based on guideline-defined threshold. Explanatory
variables were a participant’s comorbidity profile, characterized by the presence of
specific chronic condition types (none, concordant only, discordant only, and both
concordant and discordant). Analyses included logistic regression adjusted for survey
years, socio-demographic, clinical and lifestyle characteristic factors.
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Results: In the final study sample, (66%) were had both concordant and discordant
condition, 19% were had only concordant condition, 9% were had only discordant
condition, and only 6% were had no other chronic condition beside diabetes. We did not
find significant associations between comorbidity profile and Blood pressure control (for
concordant: OR: 0.9; 95% CI: (.05- 1.7), discordant: OR: 1.2; 95% CI: (0.6 – 2.1), and
both condition: OR: 1.0; 95% CI: (0.6 – 1.8)). Diabetes patient with only discordant
chronic condition or both concordant and discordant chronic condition were more likely
to have HbA1c controlled than those with no chronic condition beside diabetes (for
discordant: OR: 2.37; 95% CI: (1.30 – 4.33) and both condition: OR: 2.15; 95% CI: (1.18
– 3.93). The association between HDL cholesterol and comorbidity profile were modified
by race/ethnicity. Having concordant conditions was negatively associated with HDL
cholesterol control among Hispanic (OR: 0.36; 95% CI; (0.14 – 0.92). The association
was not significant among whites or blacks.
Conclusions: This study shows that Comorbidity profile is associated with ABCs goals
achievements among older adults with diabetes. Having discordant chronic conditions
makes HbA1c goal achievement more likely. However, having concordant conditions
makes HDL cholesterol goal achievement less likely: an effect that varies by
race/ethnicity. Future study should further examine the association by using
comprehensive set of chronic conditions.
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CHAPTER 1
INTRODUCTION

Type 2 diabetes mellitus (T2DM) is the seventh leading cause of death in the
United States 1. Aging is one of the risk factor for developing T2DM2. Approximately
26% of older adults have diabetes2–4 and it is projected that, in 2050, the prevalence of
diabetes in older adults will increase by 4.5 fold3. Recent studies estimated that 90% of
older adult with diabetes have one or more comorbid condition 5 , and 40% have at least
four or more conditions4–6. These multiple chronic conditions may impact diabetes care
prioritization, health care utilization, and self-management ability5. Despite a dramatic
improvement in diabetes treatment and quality of care, older adults with multiple chronic
conditions are more likely to have uncontrolled of A1C, Blood pressure and Cholesterol
level (ABCs goals) 7. Suboptimal ABCs goals were associated with a higher risk of
diabetes related complications and mortality7–9.
Improving diabetes care management may require greater attention to the type of
comorbid chronic condition. Increasingly, studies are differentiating between concordant
and discordant conditions6,10–14. Concordant conditions refer to “illnesses that overlap
with diabetes in their pathogenesis and share care goals with diabetes (e.g., heart disease,
hypertension, stroke)6.” Discordant conditions are “illnesses with unrelated pathogenesis
to diabetes or that do not share care goals or underlying predisposing factors with
diabetes (e.g., mental health illnesses, cancer, arthritis)6.” There is some evidence to

1

suggests that among older adults with diabetes, concordant conditions are associated with
better diabetes care outcomes 6,12,13 and discordant conditions are associated with poorer
diabetes care outcomes 10–12,15. However, most of these studies did not include diverse
racial/ethnic populations or the study had a crude measure of race/ethnicity (i.e., white
versus non-white).
Racial disparities in ABCs goals achievement among older adult with diabetes
have been documented 7,16,17. For example, African Americans and Hispanics with
diabetes typically have worse control of ABCs goals than whites16. Although several
explanations for observed racial/ethnic disparities are attributed to lower socioeconomic
status, inadequate health care access, poorer visit time management, fewer interactions
with the health care system, few studies have examined whether differences in
comorbidity profile can help further explain the observed differences18. A study by
Pentakota, found that discordant conditions are observed to be high in non-white groups,
but their effect on the racial disparity in ABCs goals achievement is not well
investigated12. Over all the role of comorbidity profiles in racial/ethnic disparities in
diabetes outcomes remains unclear. To address these gaps, we propose to use data from
the Health and Retirement Study (waves 2010 and 2012), to examine the association
between comorbid chronic condition profile on ABCs goals achievement among a
racially diverse sample of older adults with type 2 diabetes mellitus.
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CHAPTER 2
LITERATURE REVIEW
Diabetes Burden and Public Health Significance
Type 2 diabetes mellitus (T2DM) is the seventh leading cause of death in the
United States 1. Aging is one of the risk factor for developing T2DM2. Approximately
26% of older adults have diabetes2–4 and it is projected to increase by 4.5 fold that, in
20503. Complications due to diabetes is a major cause of disability, reduced quality of
life and death among older5,8,19. A study by Caspersen et.al20 reported that diabetes can
result in 8 years reduction in life expectancy among people aged 55 to 64. This means a
57 years old diabetic person may have an equivalent biological age to that of a 65 years
old person without diabetes20. The study by Kalyani et.al8 also demonstrated that older
adults with diabetes have a high prevalence of disabilities than older adult without
diabetes. More than 50% of older adult with diabetes reported difficulty performing daily
physical tasks21. Diabetes imposes a profound economic cost in the health care system
due to routine care for it and hospital care to treat diabetes related complications. For
example, diabetes care accounts for a total of $245 billion every year, out of this $176
billion is direct medical costs and the remaining $69 billion is for indirect cost due to
disability, work loss and premature death2.
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Cardiometabolic risk factor control among older adults with diabetes
Diabetes patient with optimal ABCs goals are associated with a reduction in risk
of diabetes related complications 7,19,22. Results in a study by Stratton et.al.23 found that a
1% reduction in HbA1c was associated with reductions in diabetes related outcomes 21% in deaths related to diabetes, 14% in myocardial infarction, and 37% in
microvascular complications 23. In another study, similar results were found among older
adults with diabetes who achieved blood pressure control goal - 32 % reduction in death
related to diabetes, 44% in stroke, and 37% in micro- vascular disease24. Currently, the
American Diabetes Association recommends control goals for adults with diabetes which
includes:- HbA1c<7.5%, BP <140/90mmHg, and LDL cholesterol <100 mg/dL25.
However, most older adult with diabetes are unable to achieve the clinical guideline goals
for controlling cardiometabolic risk factors such as blood pressure and cholesterol7,26. A
study by Casagrande et.al 7 found that 80% of people with diabetes did not achieve
ABCs goals and the prevalence of achieving blood pressure(BP) < 130/80 mmHg
decreased with increasing age. Findings suggest that, to achieve a better outcome and
reduce diabetes related complications, diabetes care quality should focus and integrate on
ABCs goals achievement, treatments and prevention.
Racial/ethnic differences in the prevalence of diabetes are well documented2,27 .
Blacks and Hispanics experience a two times higher burden of diabetes. According to
previous studies, non-Hispanics blacks (13.2%) and Hispanics (12.8%) have higher
prevalence in comparison to non-Hispanic whites (6%)2. Due to this higher burden of
diabetes, blacks and Hispanics are disproportionately affected by diabetes related
complications, which may in part be explained by poorer ABCs goals achivements18. For
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example, glycemic control is lower among Hispanics and blacks (35% and 37%
respectively) compared to whites (49%)28. Improving cardiometabolic risk factor control
among blacks and Hispanics may help to reduce the racial disparities in diabetes
outcomes. Differences in access to health care, diabetes prevention and control programs,
socioeconomic status, and neighborhood context are factors that help to explain some of
the variations observed in ABCs goals achivements16,28.However, a limited number of
studies have explored the role of multiple chronic conditions as a key factor in
contributing to disparities.
Multiple chronic conditions and burden in older adults with type 2 diabetes mellitus
In the United States, multimorbidity (or multiple chronic conditions), the presence
of two or more co-occurring chronic conditions, is common and one-third of the older
population is affected by it29. Several different approaches have been used to examine
multimorbidity. The most common way is to sum the total number of chronic
conditions6,30. However, there is no consensus regarding the number of conditions that
should be included. The type and number of conditions may depend on the data source
that is used. For example, studies that are using medical records can include about 5-62
conditions11,30. On the other hand, studies that have used nationally representative
population-based datasets that rely on self-reports such as the National Health and
Nutrition Examination Survey (NHANES), Behavioral Risk Factor Surveillance Study
(BRFSS), and the Health and Retirement Study (HRS) have used up to 8 conditions to
characterize multimorbidity6,31.
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Multiple chronic conditions and type 2 diabetes mellitus
Multiple chronic conditions are common in older adult with diabetes. Studies by
Guneir et.al5 estimates that 90% of older adults with diabetes have one or more chronic
conditions, and 40% have five or more conditions 5. Having multiple chronic conditions
can impact the quality of life and health care utilization5 . For example, emergency visits
and hospitalizations were four times higher among older adults with five or more
comorbid conditions compared to those without chronic conditions5. In addition, multiple
chronic conditions are associated with less engagement in diabetes self-management
activities 6,10. For example, the presence of cancer or arthritis may eclipse the priority of
diabetes care and make its self-management much more difficult.
There is a lack of evidence-based guidelines to care for type 2 diabetes mellitus
patients with specific disease clusters32,33. To our knowledge, there is no clear guidance
in placed on how to manage, integrate and prioritize care for multiple chronic conditions
and only little is known how diabetes management affected by the presence of comorbid
conditions31,32,34. To achieve better health outcomes among diabetes patients with
multiple chronic conditions, furthering our understanding of the types of multiple chronic
conditions may improve diabetes management outcomes.
Piette and Kerr6 discusses how multimorbidity profiles may have a great impact
on diabetes care outcomes. In their typologies for comorbid chronic conditions, they
suggested to classify chronic condition based on their characteristic
(concordant/discordant). Concordant conditions are those that have related management
and pathogenesis with diabetes e.g. hypertension heart failure and cerebrovascular
diseases. When the condition is concordant the provider may be able to provide more
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integrative and synergistic care. Discordant conditions are those have unrelated
management and pathogenesis with diabetes e.g. arthritis and cancer. In the presence of
discordant conditions, it is difficult for providers to integrate care and may also encounter
drug-drug interactions34.
Data from a limited number of studies support this concepts 6,12,13, For example, a
retrospective cohort study by Pentakota et.al12 examined veterans with new onset of
diabetes to evaluate the relationship between diabetes care and the type of comorbidity
(i.e. whether comorbidities were discordant or concordant). In this study, diabetes care
was measured by number of visits per year (face to face visit), level of HbAc1 and LDL
cholesterol. The findings suggested that patients with concordant conditions had better or
similar quality of cares (Magnan et.al). For example, the odds of getting tested for HbA1c
as per guideline is 17% higher in patients with concordant condition compered to patient
with no comorbidity (OR: 1.17; 95%CI: (1.09 -1.25) ; whereas, patients with discordant
conditions had poorer quality of care (the discordant group had 12% lower odds of
meeting the guideline)12. Another study found inconsistence care response for diabetes
with discordant condition, observed both better and worse diabetes cares13. However, the
study has limitations, first the study excluded patients with limited life expectancy or
terminal conditions (e.g metastatic cancer) that limited examination of the impact of total
number of discordant condition including serious conditions that might have a greater
impact on diabetes care. Second, the study was conducted in the VA, which serves
mainly male elderly patients population, and had limitation on its generalizability. The
other study also used data from a Midwest population that is not racially diverse as
general population. The present study proposed to use data from HRS that is as racially
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diverse as the general us population, which offers an excellent opportunity to examine
racial/ethnic disparity in diabetes care.
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CHAPTER 3
METHODS
Study Aim
The main aim of this study was to examine the association between chronic
condition profiles on ABCs goals achievement among a diverse sample of older adults
with type 2 diabetes mellitus. Specifically, the objective was to analyze the association
between comorbidity profile type and ABCs goals achievement by race/ethnicity among
older adults with type 2 diabetes.
Study design
This study is a cross- sectional study design employing data from the Health and
Retirement Study (HRS).
Data Source
Data from Health and Retirement Study (HRS), year 2010 and 2012 database
were used for this study. More specifically we combined data from the core interviews,
the biomarker dataset, and the RAND HRS datafiles (cleaned, processed, and streamlined
collection of variables from HRS). HRS is biennial longitudinal panel survey that is
nationally representative of Americans age 50 and older. The HRS over-samples
Hispanic and Black individuals and sampling weights are provided. Interview is
conducted every two years by telephone or in person. The study is funded by the National
Institute of Aging and conducted by the Institute for Social Research at the University of
Michigan. Detail about the study can be found in (http://hrsonline.isr.umich.edu/).
9

Study Population
Our sample was limited to individuals who have type 2 diabetes mellitus.
Participants included in this study are those who have been told by a doctor that they had
the disease. If participant reports not having diabetes at the time of interview, they were
consider not having diabetes and were exclude from this study (n= 11,311). Individuals
who were missing all three outcome variables (blood pressure, HbA1c and LDL
cholesterol; n= 3) were excluded. In addition, individual who were self-reported
race/ethnicity as other or missing race/ethnicity variable (n=142) were excluded yielding
analytic samples of 3567 individuals.
Definition of variables
Dependent variable
This study assessed three outcome variables: HbA1c, HDL and blood pressure.
HDL and HbA1c was collected using dried bold spot technique. In 2010 wave, the
Heritage Laboratory was used to assay total cholesterol and HbA1c. In 2012 wave, the
University of Washington was used to assay both total cholesterol and HbA1c level36.
Blood pressure was measured by using an automated device that has been
validated against manual measurement36. The measurement was taken from the
respondent’s left arm and data recorded for systolic and diastolic pressure. Respondents
were instructed to sit down with both feet on the floor and their left arm comfortably
supported with the palm facing up. Then cuff was adjusted approximately half an inch
above the elbow and made direct contact with the skin. Three measurements were taken
at different time. The average of the three measurements were used for the analysis.
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Although these three variables are continuous, we categorized them as a
dichotomous variable. The cutoff point was based on American Diabetes Association
guideline-recommended diabetes control care goals and guidelines for improving the care
of the older person with diabetes mellitus25,37 : HbA1c: > 7.5% = uncontrolled; HDL
level: for female < 40 mg/dl and male < 50 mg/dl = uncontrolled; BP level: diastolic/
systolic greater than 140/90 mmHg. These three variables reflect how well
cardiometabolic risk factor control was achieved.
Independent variable
Multimorbidity were assessed based on a total of 8 chronic conditions
(hypertension, cancer, chronic lung disease, heart disease, stroke, Alzheimer’s/dementia,
psychiatric problems, and arthritis) collected in HRS. In HRS each condition was
measured by asking the respondents whether the doctor has ever told him/her has the
condition.
Cancer: was assessed by asking: “Has a doctor ever told you that you had a
cancer or a malignant tumor, excluding minor skin cancer?”
Chronic lung disease: was assessed by asking: “Has a doctor ever told you that
you had chronic lung disease such as chronic bronchitis or emphysema?”
Heart disease: was assessed by asking: “Has a doctor ever told you that you had
a heart attack, coronary heart disease, Angina, congestive heart failure, or other
heart problems?”
Hypertension: was assessed by asking: “Has a doctor ever told you that you have
Hypertension?”
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Stroke: was assessed by asking: “Has a doctor ever told you that you have a
stroke?
Arthritis: was assessed by asking: “Has a doctor ever told you that you had
arthritis or rheumatism?”
Alzheimer’s/Dementia: was assessed by asking: “Has a doctor ever told you that
you had Alzheimer disease or dementia.?”
Psychiatric problem: was assessed by asking: “Has a doctor ever told you that
you had emotional, nervous, or psychiatric problems?”
Concordant conditions included hypertension, heart disease, and stroke.
Discordant conditions included: cancer, psychiatric problems, chronic lung disease,
arthritis, and Alzheimer’s disease. Based on previous research12,38, participants was
grouped into the following categories: none chronic conditions; concordant only;
discordant only; concordant and discordant conditions.
Effect modifier
Race/ethnicity: was assessed by two different questions. Respondents were asked:
“Do you consider yourself primarily White or Caucasian, Black or African America,
American Indian, or Asian, or something else” and grouped into three different
classification: white or Caucasian, Black or African American and other. Second, they
were asked: “Do you consider yourself Hispanic or Latino?”. Single variable for
race/ethnicity was created based on the responses to the two questions. Then participant
was assigned in to three mutually exclusive categories (Non-Hispanic White, NonHispanic Black and Hispanic). Those participants reported other or have missing value
was excluded in the present study.
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Confounders/covariates
Based on prior studies6,12,13 the following variables was included as confounders:
age, sex educational level, marital status, health insurance status, number of hospital visit,
self-rated health status, diabetic medication type (oral vs insulin), hypertension
medication, and physical activity. The same question was asked in 2010 and 2012 wave
and the variable was a result of both waves.
Age: collected as a continuous variable and utilized as continuous variable in this
study
Sex: was used the same way categorized in the data set female and male
Educational level: education was measured by the years of education from 0 to 17
that the participant had finished and categorized as 1 = less than high school, 2 = high
school graduate/GED, 3 = some college, and 4 = college and above.5. In the percent
study education status, were measured by three categories, “less than high school”, “high
school” and “some college or above”.
Marital Status: were coded married if respondents report “married” and unmarried
if they report “single”, “never married”, “divorced”, “widowed”, and “separated”. If the
response was “other”, “don’t know”, “refused”, or blank it was coded as missing.
Self-rated health status: Participant were asked “Would you say your health is
excellent, very good, good, fair, or poor?” Answer options ranged from 1 (excellent) to 5
(poor). In the percent study, participant was grouped based on their response: excellent or
very good grouped as “excellent”, fair or good grouped as “good” and poor grouped as
“poor”.
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Diabetic medication type (oral vs insulin): this variable was created by combining
a response from two different questions, “Do you now use insulin?” and “Do you
currently take any diabetes medication that you take by mouth?” For both question the
response variable is “yes”, “no” or “Don’t know”. Participant was grouped in to four
groups based on their answer: oral medication, insulin, both, and neither.
BMI: calculated from weight divided by square height. Participants provided their
weight in pounds and converted to kilogram in the BMI calculation. The same way
participant asked about their height in feet and inches and converted to meters for BMI
calculation. BMI is continuous variable and was categorized in to three groups:
Under/Normal weight (<25 kg/m2); Over weight (25 kg/m2 to 30 kg/m2); Obese (>=30
kg/m2).
Physical activity: was assessed by asking three questions; "We would like to
know the type and amount of physical activity involved in your daily life? How often do
you take part in sports or activities that are vigorous, moderate or light physical activity?”
The possible responses included every day, more than once per week, once per week, one
to three times per month, or never. For the present study participant was dichotomized
into “Physically active” if the participant answer, every day, more than once per week,
once per week in one of the three physical activities, and “not physically active “if the
participant answer one to three times per month, or never in all three activities that is
intensive, moderate and light physical activities.
Health insurance status: was assessed by asking three different questions which
included, “Are you currently covered by Medicare health insurance?”; “Are you currently
covered by (Medicaid/STATE NAME FOR MEDICAID)?”; “We’d like to ask about all

14

the other types of health insurance plans you might have, such as insurance through an
employer or a business, coverage for retirees, or health insurance you buy for yourself,
including Medigap or) other supplemental coverage. If the participant answer was yes for
one of the above question they were categorized as insured and if their answer was no
they was categorized as uninsured.
Doctor Visit: participant asked to report number of doctor visit in the last two
years and it was collected as a continuous variable and recoded as a categorical variable.
Based on the previous literature the participant was grouped 12 into four groups <7, 712,13-24 and >24 visits per year.
Medication for blood pressure: participants were asked to report if they are taking
any medication to lower their blood pressure.” To lower your blood pressure, are you
now taking any medication?”. The response variables are “yes”, “no” or “Don’t know”.
Participant were grouped in to two groups based on their answer: “Yes” or “no”. If a
Participant respond was “don’t know” it was coded as missing.
Statistical Analysis
All analyses were conducted using SAS version 9.4 software. Descriptive analysis
was used to assess all study variables by comorbidity profiles. For continuous variable
means and standard deviation were reported and for categorical variable percentages and
frequencies were reported. To test for significant differences between groups we used ttest (for continuous variables) and chi-square test (for categorical variables).
We used logistic regression analyses to examine the association between
comorbidity type and each dependent variable: HbAlc, BP and HDL. Three different
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logistic regression models were constructed regardless of the ABCs goal variable being
analyzed:
Model 1: unadjusted model, it only had comorbidity type and adjusted for wave.
Model 2: model 1 + additionally adjusted for demographic characteristics (age,
educational level, marital status, income, health insurance status).
Model 3: Model 2 +additionally adjusted for self-rated health status, diabetes
medication type, BMI, physical activity, and number of doctor visits.
Model 4: Model 3 +, additionally adjusted for interaction term between
comorbidity profile and race/ethnicity. The sample was divided in the basis of
race/ethnicity and model 3 was fit and multiple logistic regression was performed.
Sensitivity Analysis
1.

To examine whether there is a systematic difference in the distribution of

study variables between 2010 and 2012 year. The frequency of each study variable was
compared (Table A.1). Over-all there were no systematic difference in the distribution of
the study variables between 2010 and 2012 years, however, few variables show
significant difference. The average age was significantly differed (2010: 68.9; 2012:
67.9; p-value = .0024). We observe significant difference in the distribution of diastolic
blood pressure (2010: 79.2mmHg; 2012: 78.0mmHg; P-value = 0.004) and systolic blood
pressure (2010: 133.7mmHg; 2012: 131.8; P-value = 0.007). Considering these results,
we adjusted for survey year in the analysis.
2.

To assess the association between the number of concordant or discordant

chronic conditions and ABCs goals achievement (Table A.2). We categorized the number
of chronic conditions in to three different groups: 0, 1-2, 3+ conditions for both
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concordant and discordant separately. There were no significant associations between
ABCs goals achievement and number of concordant chronic condition. Similarly, there
were no significant associations between HDL control and number of discordant chronic
conditions. However, having 1-2 or 3+ numbers of discordant chronic condition were
associated with greater odds of achieving HbA1c control (OR: 1.35; 95% CI: 1.08 – 1.69;
OR: 1.75; 95% CI: (1.21 – 2.53) respectively), than no having any discordant chronic
condition. Individuals with 3+ numbers of discordant chronic condition were more likely
to have blood pressure control (OR: 1.73; 95% CI: (1.07 – 2.80) than individuals who
have no chronic condition. No other significant difference was noted.
3.

To assess whether the association between comorbidity profile and HbA1c

control would change if HbA1c level was categorized based on different cut point =
8.0mmol/mol (Table A.4) A guidelines of American Diabetes Association (ADA)
recommend a cut point for HbA1c of 8.0mmol/mol for older adults with complex
multiple coexisting chronic condition, high treatment burden and shorter remaining life
expectancy. In other hand, older adults with longer remaining life expectancy and fewer
coexisting chronic condition can use a cut point of 7.5mmol/mol, which was used for our
main analysis. The result from a cut point 8.0mmol/mol, found no significant association
between comorbidity profile and HbA1c control. This result is different from the result
form main analysis (cut point 7.5mmol/mol). This result discussed in the result section.
4.

To assess whether the association between comorbidity type and blood

pressure control would change if blood pressure level was categorized based on different
cut point = 130mmHg systolic and 80mmHg diastolic (Table.A.3). For cut points
130/80mmHg, there were no significant association between blood pressure control and
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comorbidity profile. This result was similar with the result from the original cut point
(140/90 mmHg).
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CHAPTER 4
RESULTS
Descriptive Analysis
Our sample has 3532 individuals with diabetes. The highest proportion of sample
(66%) had both concordant and discordant condition besides diabetes. About 19% of
sample had only concordant condition, 9% had only discordant condition, and only 6% of
them were free of other chronic condition except diabetes (Table 4.3).
Sociodemographic characteristics by comorbidity types are presented in Table
4.1. Almost all variables were significantly associated with comorbidity profiles (Pvalue<.05). The sample average age was 67 years old and composed of 52% female, 72%
white and 61% married. Individuals with both concordant and discordant chronic
condition were significantly older (68 years) than individual with no chronic condition
(62 years) (p-value = <0.0001). The percentage of non-Hispanic white was significantly
higher among group who have only discordant chronic conditions (81%) or both
concordant and discordant chronic condition (74%) than group with no chronic condition
(66%). Among the group with both chronic condition, 55% were females, 74% were
whites, 57% were married and 61% were physically inactive. Obesity is slightly higher
among the group with both chronic condition than the group with only concordant or with
only discordant chronic conditions. The prevalence of blood pressure medication intake
was disproportionately higher in individuals with only concordant chronic conditions
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(85%) and individual with both discordant and concordant (86%) chronic conditions
compered to individuals with only discordant chronic condition (5%).
Table 4.2 illustrated the percentage of those who achieved their ABCs goals. For
the HbA1c goal, approximately, 79% of the sample met the HbA1c target of less than
7.5mmol/mol. When we look by comorbidity profile, 67% of those who have no chronic
conditions, 77 % of those who have only concordant chronic conditions, 84% of those
who have only discordant chronic conditions and 80% of those who have both chronic
conditions met the HbA1c target of less than 7.5mmol/mol. On the other hand, slightly
over half (58%) of the sample met HDL cholesterol target of < 40 mg/dl for female and <
50 mg/dl for male. When we look HDL cholesterol level control 68% of those with no
chronic condition beside diabetes, 62% of those who have only concordant chronic
conditions, 66% of those who have only discordant chronic conditions and 55% of those
who have both chronic conditions were achieved HDL cholesterol goal. Only 32 % of the
sample met all three ABCs goals (cholesterol, blood pressure and HbA1c) together.
When we look by comorbidity profile 43% of those who have only discordant condition
achieved all three targets. Among those who have only concordant chronic condition
32% of those achieved all three targets. Among those who have both chronic condition
30% of those achieved all three targets.
Table 4.3 illustrated the prevalence of comorbidity profile by race/ethnicity. The
proportion of having only concordant chronic conditions were greater among blacks
(20%) than whites (17%) however, proportion of having only discordant chronic
conditions were smaller among blacks (4%) than whites (10%). Proportion of having
both concordant and discordant chronic conditions were greater among blacks (71%) than
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whites (68%). Proportion of having only concordant chronic conditions were highest
among blacks (20%) comparing to Hispanics (13%) and whites (17%). The Proportion of
having both concordant and discordant chronic conditions were smaller among Hispanics
(55%) than whites (71%) and blacks (68%).
Statistical Analysis
The results from unadjusted and adjusted logistic regression model for each
cardiometabolic risk factor control was presented in table 4.4.
HbA1c models: When only adjusting for survey year (model 1) having only
concordant, only discordant, or both chronic conditions were associated with
significantly increased odds of HbA1c control compared to having no chronic conditions,
(for concordant: OR: 1.61; 95% CI: (1.05-2.47), discordant: OR:2.54; 95% CI: (1.42 –
4.53), and both condition: OR: 1.97; 95% CI: (1.28 – 3.03)). Similarly after adjusting for
socio-demographic variables, having only concordant chronic conditions, only discordant
chronic conditions, or both chronic conditions were associated with significantly
increased odds of HbA1c control, (for concordant: OR: 1.66; 95% CI: (1.13 - 2.45),
discordant: OR:2.11; 95% CI: (1.22 – 3.64), and both condition: OR: 1.61; 95% CI:
(1.08 – 2.40)). Finally, after adjusting for clinical factors and lifestyle characteristic
variables the association was slightly higher and remained significant (for concordant:
OR: 1.88; 95% CI:(1.08 – 3.27), discordant: OR: 2.37; 95% CI: (1.30 – 4.33), and both
condition: OR: 2.15; 95% CI: (1.18 – 3.93). An interaction term between race/ethnicity
and comorbidity profile was assessed in the fully adjusted model; but was not significant
(P =0.52).
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HDL Cholesterol model. When only adjusting for survey year, having both
(concordant and discordant) chronic conditions were negatively associated with HDL
control (OR: 0.58; 95% CI:( 0.41 – 0.82). However, having only concordant or only
discordant chronic conditions were not significantly associated with HDL cholesterol
control. After controlling for socio-demographic variable, the result was remained the
same, having both (concordant and discordant) chronic conditions were less likely to
achieving HDL control comparing to those with no chronic conditions (OR: 0.7; 95% CI:
(0.49 - 0.99). However, after adjusting for clinical factors and lifestyle characteristic
variables there were no significant association noted between chronic condition profiles
and HDL control. Lastly, by using fully adjusted model, race/ethnicity was assessed as
modifiers of the association between HDL control and comorbidity profiles. The
interaction between race/ethnicity and comorbidity profile were significant (p-value
=0.03). Table 5 illustrates the association between comorbidity type and HDL control
level by race/ethnicity. For white and black no association was observed between
comorbidity profile and HDL cholesterol control. Similarly, there were no significant
association between having discordant or both (concordant and discordant) chronic
conditions and HDL cholesterol control among Hispanics. However, Hispanics with
concordant chronic conditions were less likely to control their HDL cholesterol level than
those Hispanic with no chronic condition beside diabetes (OR: 0.39; 95% CI: (0.16 –
0.95).
Blood pressure model. For all three model (model 1, model 2 and model 3)
there were no significant associations between blood pressure control and comorbidity
profiles. Interaction term between race/ethnicity and comorbidity profile was assessed in
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fully adjusted model as modifiers of the association between blood pressure control and
comorbidity profiles however, it was not significant (P = 0.28).
All ABCs Target Model. For model 1(unadjusted model) and model 2 (after
adjusting for socio-demographic variables) we found no significant association between
comorbidity profile and all three targets achievements. In model 3, having only
discordant, or both chronic conditions were associated with significantly increased odd of
controlling all three targets compared to having no chronic conditions, (for discordant:
OR: 2.07; 95% CI: (1.15 – 3.70), and both condition: OR: 2.05;95% CI: (1.16 – 3.62))
(Table 4.6).
Table 4.7 illustrated a detail of results from the final adjusted model. After
adjusting for all covariates. Sex was associated with HDL control, compared to females,
males were significantly more likely to have a higher odd of HDL control (OR: 2.54;
95% CI: (2.02 – 3.20). Age, marital status, education, health insurance, physical activity,
face to face doctor visit and taking blood pressure medication were not significantly
associated with HDL cholesterol control. Blacks were significantly more likely to control
their HDL cholesterol level compared to whites (OR: 1.63; 95% CI:(1.26 – 2.13).
Similarly, Hispanics have a higher odds of HDL control compared to whites, it was
marginally significant (OR:1.33; 95% CI: (1.03 – 1.70). Individuals who intake oral
diabetes medication or those who intake both oral and insulin diabetes medications were
less likely to control their HDL cholesterol level compared to those with no diabetes
medication (OR:0.54; 95% CI: (0.36 - 0.84) and OR: 0.60; 95% CI: (0.43 - 0.80)
respectively. Similarly, individual with poor self-rate health status less likely to control
their HDL cholesterol level compared to those with good self-rate health status (OR:
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0.78; 95% CI: (0.63 – 0.96). Overweight or obese were related to lower odds of HDL
cholesterol control compared to normal weight (OR: 0.64; 95% CI: (0.52 - 0.82) and OR:
0.54; 95% CI: = (0.40 - 0.37) respectively.
Blacks were significantly less likely to control their HbA1c level compared to
whites (OR: 0.67; 95% CI: (0.46 - 0.98). Sex, age, marital status, BMI, self-rate health
status, education, health insurance, physical activity and face to face doctor visit were not
significantly associated with HbA1c control. Individual who take any kind of diabetes
medication were less likely to control their HbA1c level compared to those who do not
take any diabetes medication. In other hand individual with poor self-rate health status
less likely to control their HbA1c level compared to those with good self-rate health
status (OR: 0.74; 95% CI:(0.56 – 0.96). Individual with high school diploma were less
likely to control their blood pressure level compared to individual with some college
degree or higher education status (OR:0.71; 95% CI: (0.54 - 0.95). Like HbA1c control,
blacks were significantly less likely to control their blood pressure compared to whites
(OR:0.58; 95% CI: (0.44 – 0.77). Hispanics were less likely to control their HbA1c level
compared to whites, (OR:0.71; 95% CI:(0.53 – 0.93). Finally, sex, marital status, BMI,
self-rate health status, health insurance, physical activity, diabetes medication intake, and
face to face doctor visit were not significantly associated with blood pressure control.
(Table 4.7)
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Table 4.1. Characteristic of participant by comorbidity profile, Health and Retirement Study, 2010 and 2012
Total

None

Concordant only

Discordant only

Both

(Ne =3532)

(ne= 185)

(ne=657)

(ne=266)

(ne= 2424)

%

%,

%

p-value a

%

p-value b

%

p-value c

67.3

62

64

<0.001

65

<0.001

68

<0.001

Female

52

46

39

0.15

55

0.14

55

0.09

Male

48

54

61

Non-Hispanic White

72

66

66

Non-Hispanic black

14

12

15

6

15

Hispanic

14

22

19

13

11

Married

61

70

65

Not married

40

30

35

Characteristic

Age (Mean) years
Sex (%)

45

45

25

Race/ethnicity (%)
0.64

81

0.0007

74

0.0005

Marital status (%)

Vigorous physical activity (%)

0.46

72
28

0.74

57
43

0.02

Active

45

63

49

0.002

62

0.79

Not active

55

37

51

<7 per 2 years

54

80.5

69

7 -12 per 2 years

24

13

19

22

27

13-24 per 2 years

2

0.5

2

2

3

24+ per 2 years

20

6

11

17

24

Oral

55

56

63

Insulin

8

10

5

6

9

Both

13

5

10

10

15

Non

24

29

22

35

22

Normal

15

30

17

Over weight

31

31

35

36

29

Obese

54

39

48

44

58

38

39

<.0001

61

Total face to face visits (%)
0.06

59

<.0001

46

<.0001

Diabetes medication (%)

26

0.01

49

0.04

54

0.007

BMI (%)
0.0029

20

0.11

13

<.0001

Self-rate health status (%)
Poor

51

27

39

0.03

33

0.3

Good

49

73

61

Insured

93

88

86

Uninsured

7

11

14

4

5

<high school

27

20

23

21

29

High school

28

19

28

>some college

45

61

29

Yes

74

1

85

No

26

99

14

67

58

<.0001

42

Health insurance (%)
0.6

96

0.03

95

0.03

Education (%)

27

0.09

26

0.34

53

30

<.0001

41

Blood pressure medication (%)
<.0001

5
97

0.19

86

<.0001
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a. P-value represents the comparison of variables between individuals who do have concordant chronic condition and those who do not have
chronic condition except diabetes; b. P-value represents the comparison of variables between individuals who do have discordant chronic
condition and those who do not have chronic condition except diabetes; c. p-value represents the comparison of variables between individuals
who do have both concordant and discordant chronic condition and those who do not have chronic condition except diabetes; d. Bold font
represents a significant p-value.; e. HRS consider weighted percentage in account

Table 4.2. Percentage of participant who achieved each ABCs goal by comorbidity
profile, Health and Retirement Study, 2010 & 2012.

ABC goals
achievement

Control
Uncontrolled

Total
(N, %)

None
Concordant
(N, %)
(N, %)
HbA1c a

Discordant
(N, %)

Both
(N, %)

2743 (79)

121 (67)

479 (77)

213 (84)

1930 (80)

789 (21)

64 (33)

178 (23)

53 (16)

494 (20)

HDL Cholesterol b
Control
Uncontrolled

2054 (58)
1478 (42)

123 (68)

398 (62)

176 (66)

1357 (55)

62 (32)

259 (38)

90 (34)

1067 (45)

Blood pressure c
Control
Uncontrolled

2337 (69)

131 (71)

400 (64)

209 (77)

1597 (69)

1195 (31)

54 (29)

257 (36)

57 (23)

827 (31)

All three goals
Control
Uncontrolled
a.
b.
c.

1080 (32)

61 (33)

190 (32)

110 (43)

719 (30)

2452 (68)

124 (67)

467 (68)

156 (57)

1705 (70)

HbA1c control <7.5 mmol/mol
HDL control for female <50 mg/dL and for male < 40 mg/dL
Blood pressure control systolic <140/90 mmHg
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Table 4.3. Distribution of comorbidity profiles by race/ethnicity, Health and Retirement
Study, 2010 & 2012

Comorbidity
type (%)

Total, N
(%)

Black, N
(%)

Hispanic, N (%)

White, N (%)

Concordant

657 (19)

176 (20)

170 (13)

311 (17)

Discordant

266 (9)

37 (4)

53 (8)

176 (10)

Both

2424 (66)

618 (71)

358 (55)

1448 (68)

None

185 (6)

39 (5)

60 (10)

86 (5)
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Table 4.4. Crude and adjusted association between comorbidity profiles and each ABCs goal achievement, Health and Retirement
Study ,2010 & 2012

HDL Cholesterol

Type

Concordant

Model 2b

Model 3

Model 1

Model 2

Model 3

Model 1

Model 2

Model 3

OR

OR

OR

OR

OR

OR

OR

OR

OR

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95%CI)

(95%CI)

(95% CI)

0.77

0.71

1.03

1.61

1.6 6

1.88

0.73

0.8

0.9

(0.50 – 1.16) (0.46 – 1.08)

30
Noned

1.00

(0.58 – 1.41) (0.63 – 1.57)
0.58

Both

Blood Pressure

Model 1a

0.91

Discordant

HbAc1

0.62

(0.64–1.66)
1.27
(0.77–2.11)
1.06

(0.41 – 0.82) (0.43 – 0.89) (0.67–1.66)
1

1

1

(1.05 – 2.47) (1.13 – 2.45) (1.08–3.27)
2.54

2.11

2.37

(1.42 – 4.53) (1.22 – 3.64) (1.30 –4.33)
1.97

1.61

2.15

(1.28 – 3.03) (1.08 – 2.40) (1.18 – .93)
1

1

1

(0.4 – 1.3) (0.4 – 1.4)

(0.5 – 1.7)

1.3

1.3

1.2

(0.7 – 2.4)

(0.7 – 2.4)

(0.6 – 2.1)

0.89

1.0

1.0

(0.5 – 1.4)

(0.6 – 1.6)

(0.6 – 1.8)

1

1

1

a. Model 1: Unadjusted model
b. Model 2: Model 1 and additionally adjusted for Socio-demographic covariates: - age, gender, race/ethnicity, marital status, education status, health-insurance
c. Model 3: model 2 and additionally adjusted for BMI, self-rated health, physical activity, smoking status, medication for hypertension, medication for diabetes,
face to face doctor visits
d. Reference group
e. Bold font represents significant 95% CI

Table 4.5. Adjusted association between comorbidity profiles and HDL control by race,
Health and Retirement Study, 2010 & 2012

HDL
Non-Hispanic white

Non-Hispanic black

Hispanic

OR

(95% CI)

OR

(95% CI)

OR

(95%CI)

Concordant

1.63

0.85 – 3.14

0.44

0.11 – 1.76

0.39

0.16 – 0.95

Discordant

1.76

0.89 – 3.48

0.71

0.19 – 2.69

0.80

0.26 – 2.43

Both

1.48

0.80 – 2.75

0.50

0.15 – 1.63

0.51

0.23 – 1.13

Comorbidity type

None b

1

1

1

a. Adjusted for wave, comorbid condition, age, gender, race/ethnicity, marital status, education status,
health insurance, BMI, self-rated health, physical activities, smoking status, medication for hypertension,
medication for diabetes, face to face doctor visits
b. Reference group
c. Bold font represents significant 95% CI
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Table 4.6. Crude and adjusted association between comorbidity profiles and all ABCs
goals achievement, Health and Retirement Study ,2010 & 2012

All three goals
Comorbidity Type

Concordant

Discordant

Both

Noned

Model 1a

Model 2b

Model 3c

OR (95% CI)

OR (95% CI)

OR (95% CI)

0.97

1.03

1.79

(0.59 – 1.58)

(0.64 – 1.64)

(0.98 – 3.28)

1.59

1.66

2.07

(0.91 – 2.76)

(0.98 – 2.82)

(1.15 – 3.70)

0.91

1.04

2.05

(0.58 – 1.40)

(0.69 – 1.56)

(1.16 – 3.62)

1

1

1

a. Model 1: Unadjusted model
b. Model 2: Model 1 and additionally adjusted for Socio-demographic covariates: - age, gender,
race/ethnicity, marital status, education status, health-insurance
c. Model 3: model 2 and additionally adjusted for BMI, self-rated health, physical activity, smoking
status, medication for hypertension, medication for diabetes, face to face doctor visits
d. reference groups
e. Bold font represents significant 95% CI
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Table 4.7. Results from the final model examining association between comorbidity profiles and ABCs goals achievement, Health and
Retirement Study, 2010 & 2012

Variable

HDL Cholesterol

HbAc1

OR (95% Confidence Interval) OR (95% Confidence Interval)

Blood Pressure
OR (95% Confidence Interval)

1.03 (0.64 – 1.66)

1.8 (1.0 – 3.2)

0.9 (0.5 – 1.7)

Discordant

1.27 (0.77 – 2.11)

2.3 (1.3 – 4.3)

1.2 (0.6 – 2.1)

Both

1.06 (0.67 – 1.66)

2.1 (1.1 – 3.9)

1.0 (0.6 – 1.8)

None

1

1

1

0 .99 (0.98 – 1.01)

1.88 (1.08 – 3.27)

0.97 (0.96 -0.99)

1

1

1

2.54 (2.02 – 3.20)

1.11 (0.82 – 1.50)

0.71 (0.59 – 0.86)

1

1

1

1.63 (1.26 – 2.13)

0.67 (0.46 – 0.98)

0.58 (0.44 – 0.77)
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Concordant

Age (Mean) years
Sex (%)
Female a
Male
Race/ethnicity (%)
Non-Hispanic White a
Non-Hispanic black

1.33 (1.03 – 1.70)

0.74 (0.48 – 1.13)

0.71 (0.53 – 0.93)

1

1

1

0.86 (0.70 – 1.07)

1.06 (0.82 – 1.37)

1.13 (0.91 – 1.39)

Less than high school

0.88 (0.71 – 1.11)

0.91 (0.68 – 1.22)

0.71 (0.54 – 0.95)

High school

1.08 (0.81 – 1.44)

0.78 (0.57 – 1.08)

0.70 (0.54 – 0.92)

1

1

1

Insured a

1

1

1

Uninsured

0.82 (0.51 – 1.33)

0.56 (0.39 – 0.82)

0.74 (0.54 – 1.06)

1

1

1

0.95 (0.78 – 1.17)

0.74 (0.54 – 1.03)

1.03 (0.85 – 1.24)

0.84 (0.62 – 1.13)

0.82 (0.56 – 1.21)

0.70 (0.52 – 0.95)

Hispanic
Marital status (%)
Married a
Not married
Education (%)

Some college or greater a
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Health insurance (%)

Physical activity (%)
Active a
Not active
Total F2F visits (%)
<7 per 2 years

7 -12 per 2 years

0.75 (0.57 – 1.00)

1.00 (0.71 – 1.42)

0.89 (0.69 – 1.14)

13-24 per 2 years

0.99 (0.46 – 2.10)

0.75 (0.34 – 1.67)

0.67 (0.38 – 1.19)

24+ per 2 years a

1

1

1

Insulin

0.93 (0.72 – 1.20)

0.39 (0.26 – 0.60)

1.45 (1.09 – 1.98)

Oral

0.54 (0.36 – 0.84)

0.11 (0.07 – 0.18)

1.27 (0.81 - 1.98)

Both

0.60 (0.43 – 0.80)

0.12 (0.07 – 0.19)

1.49 (1.09 – 2.03)

None a

1

1

1

1

1

1

Over weight

0.64 (0.52 – 0.82)

0.59 (0.40 – 0.88)

1.11 (0.78 – 1.58)

Obese

0.54 (0.40 – 0.73)

0.72 (0.48 – 1.10)

1.08 (0.80 – 1.46)

Poor

0.78 (0.63 – 0.96)

0.74 (0.56 – 0.96)

0.95 (0.77 – 1.18)

Good a

1

1

1

Diabetes medication (%)

35

BMI (%)
Normal a

Self-rate health status (%)

Blood pressure medication (%)

Yes

0.84 (0.65 – 1.08)

1.13 (0.75 – 1.70)

0.73 (0.55 – 0.96)

No a

1

1

1

Abbreviation: BMI, Body mass index; F2F, face to face doctor visit: a. Reference group
b.
OR from final model adjusted for wave, age, gender, race/ethnicity, marital status, education status, health-insurance, BMI, self-rated health, physical
activity, smoking status, medication for hypertension, medication for diabetes, face to face doctor visits
d.
Bold font represents significant p-value (<.05); e. BMI group Under/Normal weight (<25); Over weight (25 to 30); Obese (>=30)
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CHAPTER 5
DISCUSSION
We found that, the distribution of comorbidity profiles differed by race/ethnicity.
Hispanics had the highest percentage of individuals with no chronic condition beside
diabetes when compared with black and whites. On the other hand, the percentage of
discordant condition was higher among Hispanics and whites than blacks.
This study assessed whether there was an association between comorbidity profile
and cardiometabolic risk factor control among older adults with diabetes. Also, the study
was examined whether race/ethnicity modified the association between comorbidity
profile and cardiometabolic risk factor control. Our results show that individual with only
discordant chronic conditions are more likely to control their HbA1c level than those
with no chronic condition beside diabetes. Similarly, having both concordant and
discordant chronic conditions were associated with greater odds of HbA1c control. In
general, our results suggest that diabetes patient with discordant chronic conditions have
a better chance to control their HbA1c level than those with no chronic condition beside
diabetes. Also, we did find race/ethnicity as effect modifier between HDL control and
comorbidity profile.
Cardiometabolic risk factor control by both concordant and discordant chronic
condition
Our result also showed that diabetes patient with both discordant and concordant
chronic conditions were more likely to control their HbA1c level than patients with no
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chronic condition beside diabetes. This result is supported by another study, that reported
that diabetes patients with both concordant and discordant chronic conditions were more
likely to have better ABCs goals achievement than those of with no chronic condition
beside daiabetes39. The possible explanation for this result could be a difference in lipid
lowering medication intake among groups. The literature shows that individual with
multiple chronic condition or those with polypharmacy were more likely to receive
statins or other lipid lowering medication as compared to those with no chronic condition
beside diabetes40. Further, those taking statins was also related with lowering A1c levels,
however we were unable to capture satin medication intake in our data. Another
explanation could be because patients with more chronic conditions had more frequent
primary and specialty care visits than other patients, which may increase relationship
between provider and patients. Greater effort by health care providers such as pay
attention and examine all aspects of the patient conditions, accordingly individualize
achievement goals and the lifestyle changes help patients to achieved good HbA1c
control39,41. This suggests that having more chronic condition does not necessarily make
diabetes patents vulnerable to receiving poorer cardiometabolic risk factor control.
Cardiometabolic risk factor control by discordant chronic condition
Our results showed that diabetes patients with only discordant chronic conditions
was associated with better control of HbA1c level compared with those with no chronic
condition beside diabetes. This finding did not support our hypothesis that those with
discordant chronic conditions will have much worse ABCs goals achievement compared
to those with no chronic condition beside diabetes. However, our result is supported by
previous literature showing the same impact of discordant chronic conditions on diabetes
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care. For example, the result from Woodard et al., shows that diabetes patient with only
discordant chronic conditions were more likely to have better control of glucose and
lipids than patients with no chronic condition beside diabetes. The possible explanation
might be that individuals who had much more challenging conditions may receive better
care with frequent medication and life style changes and do better self-care than
individuals with no chronic condition beside diabetes. Another explanation could be a
difference in diabetes medication intake, we found that the prevalence of insulin intake
was greater among individual with on chronic condition beside diabetes (10%) than
individual with only discordant chronic condition (5%). This finding was further
supported by the finding from other literatures, suggested that insulin intake is associated
with lower HbA1c control7,22.
However, our result is in contradict with the Pentakota et al.12 study, suggests that
discordant condition reduced quality of diabetes care. This inconsistent result may be
due to the fact the Pentakota study excluded patients with life threatening conditions
which other study show high risk patients received better provider attention and increased
a chance to received better care11.
Cardiometabolic risk factor control by concordant chronic condition
Our results found no association between having concordant chronic conditions and
ABCs goal achievements. We found no difference on achieving ABCs goals between
those who have concordant chronic conditions compared to those with no chronic
condition. Possible explanation could be attributed to the fact we only included a limited
number of concordant chronic conditions (n= 3). In addition to that patients with this
conditions (stroke, hypertension and heart disease) mostly gives much less attention to
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goal achievement prioritizations and lifestyle changes than patients who has other
concordant chronic condition (e.g renal disease & diabetes eye disease) which was not
capture in our data6. Therefore, it may possible this may buffer the effect of concordant
chronic conditions on ABCs goals achievement. However, research has found having
concordant chronic condition was associated with better ABCs goals achievements13.
Race/ethnicity does not appear to modify the association between HbA1c control
and comorbidity profile or blood pressure control and comorbidity profile. A possible
explanation to our null findings were a small sample size for Hispanic and black
participants by comorbidity profiles (Hispanic discordant n = 53 and black discordant n =
37). Furthermore, race/ethnicity modified the association between HDL control and
comorbidity profiles. We found Hispanics with concordant chronic conditions less likely
to control their HDL level than Hispanic with no chronic condition (OR: 0.39; 95% CI:
(0.16 – 0.95)).
Strengths and Limitations
The present study has several strengths. First, it uses HRS data, which is a
nationally representative sample of persons 50 years of age. In addition to the nationallyrepresentative, multi-stage area probability sample, it over sampled black and Hispanic
populations to increase generalizability. Second, all outcome variables, blood pressure,
HDL cholesterol, and HbA1c were from HRS biomarker dataset, which are measured
objectively. Finally, we assessed association between ABCs goals achievement and
comorbid chronic condition by using comorbidity profile (concordant and discordant),
rather than just looing the number of chronic conditions, which ignores a potentially
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important consideration; whether the comorbidity has similar or opposite management to
diabetes.
However, there are several limitations in the present study. The first limitation is,
the fact that it is a cross-sectional study, it is possible that increased numbers of comorbid
conditions are the result of, rather than the cause of, poor cardiometabolic risk factor
control. Therefore, we can only suggest association, not causality. Second, except for the
cardiometabolic risk factor variables (BP, HbA1c and HDL), type 2 diabetes and other
chronic condition were assessed based on self-report information and not verified by
medical records review. This, make the information less reliable and bias may occur due
to the misclassification of diabetes and other chronic condition variables. However, study
suggest that although strength of agreement varied by conditions, there is good
agreement between validated evidence of chronic condition and self-report of chronic
disease42. Fourth, recall bias could weaken the true effect of comorbidity on ABCs goals
achievements. Fifth, while we examine the effect of comorbidity by their type
(concordant/ discordant) we looked for presence or absence of condition, and we were
not able to assess chronic severity level that might influence ABCs goals achievement11.
Sixth, we included small numbers of common chronic conditions to classify patients into
comorbid chronic condition groups; however, the condition may not reflect all existing
chronic conditions and it may lead to underestimating the impact of comorbidity profiles
in our outcome. Finally, physical activity was poorly measured, and diet was not
measured. Furthermore, even if the present study adjusted for so many covariant, it is
plausible to acknowledge that there may be unmeasured confounders (e.g., polypharmacy
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and diabetes duration and medication adherence) for which we could not make
adjustments.
Conclusion
Our study indicates that diabetes patients with multiple chronic conditions have a
better or similar ABCs goals achievement compared to individuals with no chronic
condition beside diabetes, particularly those with discordant chronic conditions regardless
of race/ethnicity. However, the impact of concordant chronic conditions differed by
race/ethnicity. Hispanics with concordant chronic conditions were less likely to achieve
HDL cholesterol goals but no association was found among whites or blacks. These
findings suggest the need for strategies that focus on identifying patients who might be at
high risk of controlling their ABCs goals and the development of interventions that
account for individuals’ comorbidity profiles and race/ethnicity. Future studies should
further examine the association longitudinally and use a comprehensive set of chronic
conditions.
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APPENDIX. A SENSITIVITY ANALYSIS
Table A.1. Comparison of socio-demographic and clinical variables for 2010 and 2012 Health and Retirement Study

Variables
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Exposure (%)
None
Concordant
Discordant
Both
Outcome (mean, SD)
Systolic blood pressure
Diastolic blood pressure
HbA1c
HDL
Covariant
Age (Mean) years
Sex (%)
Female
Male
Race/ethnicity (%)
None Hispanic White
None Hispanic black
Hispanic
Marital status (%)
Married
Not married

2010 wave
2012 wave P-value a
N, Means %, SD N, means %, SD
95
313
127
1,313

6.0
18
7
68

90
344
139
1,111

5.8
19
10
64

133.7
79.2
6.8
49.9

21.1
12.3
1.5
14.3

131.8
78
6.8
49.6

20.1
12
1.4
14.3

0.0075
0.004
0.89
0.56

68.9

10.2

67.6

9.8

0.0024

1034
814

53
47

898
786

51
49

0.33

1087
440
321

73
14
13

934
430
320

71
15
14

1104
744

61
39

1004
680

61
39

0.11

0.5

0.9
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Vigorous physical activity (%)
Active
Not active
Diabetes medication (%)
Insulin
Oral
Both
None
BMI (%)
Normal
Over weight
Obese
Self-rate health status (%)
Poor
Good
Health insurance (%)
Insured
Uninsured
Education (%)
<high school
High school
>some college
Blood pressure medication (%)
Yes
No
* P-value represents the comparison of variables between wave 2010 and wave
- Bold font represents a significant p-value

721
974

44
56

678
969

45
55

0.7

995
162
237
454

54
8
13
25

970
148
247
319

56
8
13
21

0.4

315
602
931

16
17
52

262
511
911

15
29
56

0.24

989
859

51
49

909
775

50
50

0.66

1700
141

93
7

1542
137

92
8

0.61

560
562
726

25
30
45

560
459
665

29
26
45

0.05

1392
456

74
26

1291
393

74
26

0.96

Table A.2. Impact of the number of discordant and concordant condition on
cardiometabolic risk factor control

HbAc1control

HDL Cholesterol
Control

Blood pressure
control

Number of concordant
Condition
OR (95% CI)

OR (95% CI)

OR (95% CI)

Concordant
0a
1-2

1
1.29 (0.80 – 2.08)

1
0.91 (0.66 – 1.25)

3+

1.16 (0.60 – 2.24)

1.05 (0.68 – 1.62)

1
0.97 (0.67 –
1.42)
0.93 (0.48 –
1.80)

Discordant
0a
1-2

1
1.35 (1.08 – 1.69)

1
1.06 (0.81 – 1.39)

3+

1.75 (1.21 – 2.53)

0.93 (0.64 – 1.35

b

1
1.10 (0.80 –
1.51)
1.73 (1.07 –
2.80)

Adjusted for wave, age, gender, race/ethnicity, marital status, education status, health insurance, BMI,
self-rated health, physical activities, smoking status, medication for hypertension, medication for
diabetes, face to face doctor visits
a
Reference groups
Bold font represents significant 95% CI
c
This group has a very small number and interpretation for result should be with caution
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Table A.3. The association between comorbidity type and Blood pressure level with cutpoint 130/80 and 140/90, Health and Retirement Study, 2010 & 2012

Comorbidity type
Concordant

Cut-point=130/80 mmHg
OR b
95% CI
0.89
0.47 - 1.69

Cut-point=140/90mmHg
OR
95% CI
0.9
0.5 – 1.7

Discordant

1.03

0.64 – 1.63

1.2

0.6 – 2.1

both

1.12

0.65 – 1.93

1.0

0.6 – 1.8

None a

1

1

a

Adjusted for wave, age, gender, race/ethnicity, marital status, education status, health insurance, BMI,
self-rated health, physical activities, smoking status, medication for hypertension, medication for
diabetes, face to face doctor visits
b
Reference groups
c
Bold font represents significant 95% CI
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Table A.4. The association between comorbidity type and HbA1c level with cut-point 7.5
and 8.0, Health and Retirement Study, 2010 & 2012

Comorbidity type

Cut-point = 8.0

Cut-point = 7.5

Concordant

OR
1.62

95% CI
0.77 – 3.41

OR
1.8

95% CI
1.0 – 3.2

Discordant

1.73

0.83 – 3.61

2.3

1.3 – 4.3

both

1.86

0.88 – 3.91

2.1

1.1 – 3.9

1

1

None a

1

b

Adjusted for wave, age, gender, race/ethnicity, marital status, education status, health insurance, BMI,
self-rated health, physical activities, smoking status, medication for hypertension, medication for diabetes,
face to face doctor visits
a
Reference groups
Bold font represents significant 95% CI
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